(19)
(11) EP 1 866 339 B8

(12) CORRECTED NEW EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B2)

(48) Corrigendum issued on:
01.12.2021 Bulletin 2021/48

(45) Date of publication and mentionof the opposition decision:
15.09.2021 Bulletin 2021/37

(45) Mention of the grant of the patent:
29.05.2013 Bulletin 2013/22

(21) Application number: 06748745.4

(22) Date of filing: 27.03.2006
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
A61P 31/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/12; C07K 2317/75; A61K 2039/505; C07K 2317/92; A61P 37/04; C07K 2317/56; C07K 16/2878; A61K 39/0011; A61P 31/02; Y02A 50/30; A61P 35/00; A61P 35/02; A61P 43/00; A61P 31/04; C07K 2317/24; C07K 2317/54; A61P 31/00
(86) International application number:
PCT/US2006/011114
(87) International publication number:
WO 2006/105021 (05.10.2006 Gazette 2006/40)

(54)

GITR BINDING MOLECULES AND USES THEREFOR

GITR-BINDENDE MOLEKÜLE UND IHRE VERWENDUNG

MOLECULES DE LIAISON GITR ET LEURS UTILISATIONS


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 25.03.2005 US 665322 P
03.06.2005 US 687265 P

(43) Date of publication of application:
19.12.2007 Bulletin 2007/51

(60) Divisional application:
10181638.7 / 2343320

(73) Proprietor: GITR, Inc.
Cambridge, MA 02141 (US)

(72) Inventors:
  • SMITH, L., Mary
    Dedham, Massachusetts 02026 (US)
  • SZYMANSKA, Grazyna
    Dedham, Massachusetts 02026 (US)
  • PONATH, Paul
    San Francisco, CA 94114 (US)
  • ROSENZWEIG, Michael
    Boston, Massachusetts 02118 (US)
  • PONTE, Jose, F.
    Hanover, MA 02339 (US)

(74) Representative: Grund, Martin 
Grund Intellectual Property Group Patentanwalt und Solicitor PartG mbB Postfach 44 05 16
80754 München
80754 München (DE)


(56) References cited: : 
WO-A-03/006058
   
  • SHIMIZU JUN ET AL: "Stimulation of CD25+CD4+ regulatory T cell through GITR breaks immunological self-tolerance" NATURE IMMUNOLOGY, NATURE PUBLISHING GROUP,, GB, vol. 3, no. 2, 20 February 2002 (2002-02-20), pages 135-142, XP002247979 ISSN: 1529-2908 cited in the application
  • KANAMARU FUMIKO ET AL: "Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells" JOURNAL OF IMMUNOLOGY, vol. 172, no. 12, 15 June 2004 (2004-06-15), pages 7306-7314, XP009076431 ISSN: 0022-1767
  • NOCENTINI G ET AL: "A NEW MEMBER OF THE TUMOR NECROSIS FACTOR/NERVE GROWTH FACTOR RECEPTOR FAMILY INHIBITS T CELL RECEPTOR-INDUCED APOPTOSIS" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 94, no. 12, June 1997 (1997-06), pages 6216-6221, XP002061244 ISSN: 0027-8424 cited in the application
  • KO KUIBEOM ET AL: "Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3(+)CD25(+)CD4(+) regulatory T cells" JOURNAL OF EXPERIMENTAL MEDICINE, vol. 202, no. 7, October 2005 (2005-10), pages 885-891, XP009076415 ISSN: 0022-1007
  • GURNEY A L ET AL: "IDENTIFICATION OF A NEW MEMBER OF THE TUMOR NECROSIS FACTOR FAMILY AND ITS RECEPTOR, A HUMAN ORTHOLOG OF MOUSE GITR" CURRENT BIOLOGY, CURRENT SCIENCE,, GB, vol. 9, no. 4, 15 February 1999 (1999-02-15), pages 215-218, XP002952071 ISSN: 0960-9822
  • KWON BYUNGSUK ET AL: "Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand" JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC.,, US, vol. 274, no. 10, 5 March 1999 (1999-03-05), pages 6056-6061, XP002147323 ISSN: 0021-9258
  • LITTLE M ET AL: "Of mice and men: hybridoma and recombinant antibodies" IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 21, no. 8, 1 August 2000 (2000-08-01), pages 364-370, XP004215163 ISSN: 0167-5699
  • DAVIES J ET AL: "Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding" IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 2, no. 3, September 1996 (1996-09), pages 169-179, XP004070292 ISSN: 1380-2933
  • HOLT L J ET AL: "Domain antibodies: proteins for therapy" TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 21, no. 11, November 2003 (2003-11), pages 484-490, XP004467495 ISSN: 0167-7799
  • BALINT R F ET AL: "ANTIBODY ENGINEERING BY PARSIMONIOUS MUTAGENESIS" GENE, ELSEVIER, AMSTERDAM, NL, vol. 137, no. 1, 27 December 1993 (1993-12-27), pages 109-118, XP002031537 ISSN: 0378-1119
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification